Growth and expansion BrainCo is expanding from a small team to over 100 employees with four offices worldwide, signaling increasing capacity for larger projects and regional support. This presents opportunities to upsell enterprise-grade solutions, multi-site deployments, and international training programs.

Public market ambitions Plans to go public in Hong Kong and partnerships with major banks indicate a push to scale operations and visibility. This could open doors for large, long-term contracts, strategic collaborations, and investment-influenced procurement cycles.

Medical and clinical focus Recent release of FocusXin Medical Edition for ADHD intervention shows BrainCo’s move into regulated healthcare products. This creates potential for clinical research collaborations, hospital/clinic procurement, and integration with healthcare IT systems.

BCI product expansion Launch of advanced devices such as the BrainCo Bionic Dexterous Hand Revo2 demonstrates capability in high-value hardware. Consider targeting rehabilitation centers, assistive technology programs, and OEM partnerships for device integration.

Strategic partnerships Existing collaborations with industry players and a substantial funding base suggest a favorable environment for channel partnerships, system integrators, and co-development deals to accelerate market penetration and service delivery scale.